What is the CJ Bioscience Inc. stock price forecast?

CJ Bioscience Inc. is currently trading at ₩5,080. View real-time AI analysis on Alpha Lenz.

What is CJ Bioscience Inc. insider trading activity?

View the latest insider trading data for CJ Bioscience Inc. on Alpha Lenz.

What is CJ Bioscience Inc.'s P/E ratio?

CJ Bioscience Inc.'s P/E ratio is -2.7.

CJ Bioscience Inc.

KRX · 311690

₩5,080+190(+3.89%)Market closed

Ask about CJ Bioscience Inc.'s future dividend policy...

Alpha Chat Insight

“CJ Bioscience Inc. trades at a P/E of -2.7 (undervalued) with modest ROE of -36.5%.”

Ask for details →

Company Overview

CJ Bioscience Inc. is a pioneering entity in the biotechnology sector, focusing on the development and application of advanced microbiome technologies. This company is dedicated to enhancing human health and wellness through its innovative approaches to understanding and manipulating the gut microbiome. As an integral player in the biopharmaceutical and healthcare industries, CJ Bioscience emphasizes the potential of microbiome-based therapies to treat a variety of conditions, including metabolic and immune-related disorders. The firm's research and development initiatives are aimed at harnessing the therapeutic possibilities of the microbiome, aligning with the growing interest in personalized medicine. In the financial market, CJ Bioscience Inc. represents a promising investment in the biotech field due to its commitment to cutting-edge research and its role in spearheading next-generation health solutions. This company's contributions underscore the expanding significance of biotechnology in addressing global health challenges.

CEO윤상배

Websitehttps://www.cjbioscience.com

SectorHealthcare

IndustryBiotechnology

Employees137

Company Statistics

FY 2025

Profile

₩63,890,109,180Market Cap

₩3,692,528,450Revenue

13.07MShares Out

137Employees

Margins

18.93%Gross

-509.49%EBITDA

-671.24%Operating

-650.10%Pre-Tax

-650.10%Net

Valuation

-2.66P/E

1.19P/B

17.30EV/Sales

-3.40EV/EBITDA

-2.72P/FCF

Growth (CAGR)

-3.23%Rev 3Yr

-7.01%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-27.92%ROA

-36.54%ROE

-27.29%ROIC

Financial Health

₩10,338,609,700Cash & Cash Equivalents

₩8,359,590,520Net Debt

34.86%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“CJ Bioscience Inc. trades at a P/E of -2.7 (undervalued) with modest ROE of -36.5%.”

Ask for details →

Frequently Asked Questions

CJ Bioscience Inc. (ticker: 311690) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 137 employees. Market cap is $63.9B.

The current price is ₩5,080 with a P/E ratio of -2.66x and P/B of 1.19x.

ROE is -36.54% and operating margin is -671.24%. Annual revenue is $3.7B.